Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease
Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs), such as late-stage metabolic dysfunction-associated steatohepatitis ( …